STOCK TITAN

Celsius Holdings, Inc., Reports Record Third Quarter 2022 Financial Results

Rhea-AI Impact
(Moderate)
Rhea-AI Sentiment
(Neutral)
Tags
Rhea-AI Summary

Celsius Holdings, Inc. (Nasdaq: CELH) reported a record revenue of $188.2 million for Q3 2022, reflecting a 98% increase from $94.9 million in Q3 2021. Notably, North America revenue surged 112% to $179.5 million, up from $84.5 million in the prior year. Management will discuss these results in a conference call held today at 4:30 p.m. ET.

Positive
  • Revenue increased by 98% year-over-year to $188.2 million.
  • North America revenue grew by 112% to $179.5 million.
Negative
  • None.

Revenue of $188.2 million, up 98% from $94.9 million in Q3 2021
North America revenue increased 112% to $179.5 million, up from $84.5 million in Q3 2021

BOCA RATON, Fla., Nov. 9, 2022 /PRNewswire/ -- Celsius Holdings, Inc., (Nasdaq: CELH), maker of the leading global fitness drink, CELSIUS®, today reported preliminary financial results for the third quarter ended September 30, 2022. Management will host a conference call today at 4:30 p.m. Eastern Time, to discuss the results with the investment community.

A PDF containing our third quarter 2022 results and full financial tables is available at:
https://www.celsiusholdingsinc.com/Q3_2022/

To participate in the conference call, please call one of the following telephone numbers at least 10 minutes before the start of the call:

US:

866-682-6100

International:

862-298-0702

Webcast: https://event.choruscall.com/mediaframe/webcast.html?webcastid=mzHze3ra

An audio replay of the call will be available on the same webcast link above for 90 days.

About Celsius Holdings, Inc.
Celsius Holdings, Inc. (Nasdaq: CELH), is a global consumer packaged goods company with a proprietary, clinically proven formula for its master brand CELSIUS®. A lifestyle energy drink born in fitness and a pioneer in the rapidly growing energy category. CELSIUS® offers proprietary, functional, essential energy formulas clinically-proven to offer significant health benefits to its users. CELSIUS® is backed by six university studies that were published in peer-reviewed journals validating the unique benefits CELSIUS® provides. For more information, please visit: http://www.celsiusholdingsinc.com

Forward-Looking Statements
This press release may contain statements that are not historical facts and are considered forward-looking within the meaning of the Private Securities Litigation Reform Act of 1995. These forward-looking statements contain projections of Celsius Holdings' future results of operations and/or financial position, or state other forward-looking information. In some cases, you can identify these statements by forward-looking words such as "anticipate," "believe," "could," "estimate," "expect," "intend," "may," "should," "will," "would," or similar words. You should not rely on forward-looking statements since Celsius Holdings' actual results may differ materially from those indicated by forward-looking statements as a result of a number of important factors. These factors include but are not limited to: general economic and business conditions; our business strategy for expanding our presence in our industry; anticipated trends in our financial condition and results of operation; the impact of competition and technology change; existing and future regulations affecting our business;  the Company's ability to satisfy in a timely manner, all Securities and Exchange Commission (SEC) required filings and the requirements of Section 404 of the Sarbanes-Oxley Act of 2002 and the rules and regulations adopted under that Section; and other risks and uncertainties discussed in the reports Celsius Holdings has filed previously with the Securities and Exchange Commission. Celsius Holdings does not intend to and undertakes no duty to update the information contained in this press release.

Investor Relations:
Cameron Donahue
(651) 707-3532
cdonahue@celsius.com

 

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/celsius-holdings-inc-reports-record-third-quarter-2022-financial-results-301673609.html

SOURCE Celsius Holdings, Inc.

FAQ

What were Celsius Holdings' earnings for Q3 2022?

Celsius Holdings reported a record revenue of $188.2 million for Q3 2022.

How much did Celsius revenue grow compared to Q3 2021?

Celsius revenue grew by 98% compared to Q3 2021.

What is the revenue growth for North America in Q3 2022?

North America revenue increased by 112% to $179.5 million in Q3 2022.

When will Celsius Holdings discuss their Q3 results?

Celsius Holdings will discuss their Q3 results in a conference call today at 4:30 p.m. ET.

Celsius Holdings, Inc.

NASDAQ:CELH

CELH Rankings

CELH Latest News

CELH Stock Data

6.48B
149.41M
36.09%
64.7%
11.54%
Beverages - Non-Alcoholic
Bottled & Canned Soft Drinks & Carbonated Waters
Link
United States of America
BOCA RATON